opportunities for level 3 containment research
TRANSCRIPT
Opportunities for Level 3
Containment Research
The Vaccine and InfectiousDisease Organization (VIDO) at the University of Saskatchewan is home to the International Vaccine Centre - one of the largest and most advanced level 3 containment facilities in the world, and it’s accessible to you!
SPECIALIZED EQUIPMENT
Cell sorter
Confocal microscope
In vivo imaging system
Laser microdissection system
Madison Chamber
Multicolor FACS analyzerRESEARCH LABORATORIESNumber
of RoomsRoom size
(ft2)
Standard laboratories 5 1,050
Select agent* laboratory 1 1,050
Aerobiology laboratory 1 340
Clinical pathology laboratory with associated cell sorting 1 1,025
8
ANIMAL AREASNumber
of RoomsRoom size
(ft2)
Large animal isolation rooms 14 500
Animal aerobiology isolation rooms 3 500
Animal isolation room with imaging 1 500
Necropsy suite with histology and tissue processing 1 1,410
Surgery suite with endoscopy and laparoscopy 1 670
20
WE OFFER:SUPPORT Our team helps, from start to finish, with the scientific and non-scientific aspects of your project.
VALUEYour access costs are reduced through operational support from the Canada Foundation for Innovation’s Major Science Initiatives Fund.
EXTENSIVE CAPACITYWe operate one of the largest level 3 containment facilities in North America, with the advanced research space and specialized equipment you need, including:
*Biological agents determined to have the potential to pose a severe threat to both human and animal health, plant health, or animal
Vaccine and Infectious Disease Organization / Opportunities for Level 3 Containment Research
Multicolor FACS analyzer
Surgical suiteAerobiologoy lab with Madison
Confocal microscope
Vaccine and Infectious Disease Organization / Opportunities for Level 3 Containment Research
ANIMAL EXPERTISEOur large clinical research team of veterinarians and animal research technicians specialize in the development of both small and large animal models of disease. Models can be developed or adapted to suit needs.
**EXAMPLE DISEASE MODELS
Chronic wasting disease*
Influenza
Middle East respiratory syndrome
Mycobacterium tuberculosis/bovis
Pasteurella multocida***
SARS-CoV-2
Actinobacillus pleuropneumoniae
Bordetella spp.
Bovine viruses (BHV-1, BVDV)
Campylobacter jejuni
Escherichia coli (STEC, APEC, F41)
Infectious bursal disease virus
Influenza
Lawsonia intracellularis
Mannheimia haemolytica
Mycobacterium paratuberculosis
Mycoplasma spp.
Respiratory syncytial virus
Rhodococcus equi
Salmonella spp.
Scrapie
STIs (Neisseria, Chlamydia)
Staphylococcus aureus
Streptococcus spp.
Swine viruses (PEDV, PCV, PRRSV)
Zika virus
CL3
CL2
*Risk group 2+ working in level 3 containment , **Cotton rat and/or golden hamster and/or rat and/or mouse ***Serotypes B and E Models currently in development
For more information contact:
Paul HodgsonAssociate Director – Business Development
[email protected] Verterinary Road, Saskatoon, SKCanada S7N 5E3
Come work with us.
www.vido.org